Spots Global Cancer Trial Database for Multihance Versus Magnevist in Breast MRI
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Multihance Versus Magnevist in Breast MRI
Official Title: Phase III Multicenter Double-Blind, Randomized, Crossover Study to Compare MultiHance With Magnevist in Contrast-enhanced Magnetic Resonance Imaging (MRI) of the Breast
Study ID: NCT00486473
Conditions
Study Description
Brief Summary: To show if one MRI contrast agent is better than another one in the diagnosis of malignant breast lesions compared to histopathology
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
, Rome, , Italy
Contact Details
Name: Gianpaolo Pirovano, MD
Affiliation: Bracco Dianostics, Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
